10x Genomics (TXG) statistics

Analysts' price targets and ratings, ownership, short interest, trading figures and dates for 10x Genomics, as the data feed reports them.

Analysts' mean target, 14 analysts
$68.14
21.0% above the price

The 14 analysts reported by the data feed have a mean price target for 10x Genomics of $68.14, 21.0% above the $56.30 price (range $50.00–$100.00). 13.85% of the float was sold short as of Oct 30, 2026. Institutions hold 114.2% of the shares and insiders 1.4%. Source: Yahoo Finance, read Nov 17, 2026.

Key facts

Analysts' mean target
$68.14+21.0% vs price
Analysts
14
Short interest
13.85%of float, Oct 30, 2026
Short ratio
3.13 days
Institutions
114.2%
Insiders
1.40%
Beta
2.03

Figures read . Source: Yahoo Finance (quoteSummary: key statistics, financial data, recommendation trend, major holders, insider purchases, calendar events). Analysts' targets and ratings, ownership and short interest are the data feed's figures and can lag the filings and exchange reports they come from. Figures, not advice.

Analysts' consensus as reported by the data feed

14 analysts covering 10x Genomics, as the data feed counts them. Price targets and ratings are other people's estimates — not facts about the company, and not advice. Distances are from the latest price the feed gave with these figures, $56.30.

Analysts' price targets for 10x Genomics
Mean price target$68.1421.0% above the price (+21.0%)
Median price target$65.0015.5% above the price (+15.5%)
Highest target$100.0077.6% above the price (+77.6%)
Lowest target$50.0011.2% below the price (−11.2%)
Analysts with a target14

Ratings this month · 17 analysts

Strong buy 1(6%)Buy 5(29%)Hold 11(65%)
Analysts' ratings of 10x Genomics this month, by rating
RatingAnalystsShare
Strong buy16%
Buy529%
Hold1165%
Sell00%
Strong sell00%

The feed averages these to 2.35 on its scale of 1 (strong buy) to 5 (strong sell), which it labels “buy”.

Who owns 10x Genomics

Ownership of 10x Genomics
Held by institutions114.2%633 institutions; percent of shares outstanding
Held by institutions, of the float115.8%
Held by insiders1.40%percent of shares outstanding
Shares outstanding121.46M
Float119.47Mshares available to trade
Insiders' net purchases, six months−221.12K8 purchases (57.07K shares), 16 sales (278.19K shares)

Percentages are of shares outstanding unless the row says float. Insiders' net purchases are shares bought minus shares sold by insiders, as the data feed totals their reported trades.

Short interest as reported by the data feed

Shares sold short and not yet covered, as of Oct 30, 2026. Short interest is counted twice a month, so this is not today's figure.

Short interest in 10x Genomics
Shares short12.47Mas of Oct 30, 2026
Percent of float13.85%shares short ÷ float
Percent of shares outstanding9.48%shares short ÷ shares outstanding
Short ratio (days to cover)3.13shares short ÷ average daily volume

10x Genomics short interest from FINRA, with its history

Trading figures

Trading figures for 10x Genomics
Beta2.03movement against the market; 1 moves with it
52-week high$102.81
52-week low$15.18
Average volume, 3 months3.38Mshares a day
Average volume, 10 days3.11Mshares a day

Questions and answers

What is the analysts' price target for 10x Genomics (TXG)?

As reported by the data feed, the mean price target of the 14 analysts covering 10x Genomics is $68.14, 21.0% above the latest price of $56.30. The highest target is $100.00 and the lowest $50.00. Targets are analysts' estimates, not facts about the company and not advice.

How do analysts rate 10x Genomics stock?

Of the 17 ratings the data feed reports for the current month, 1 are strong buy, 5 buy, 11 hold, 0 sell and 0 strong sell.

How many 10x Genomics shares are sold short?

As reported by the data feed, 12.47M shares were sold short, 13.85% of the float as of Oct 30, 2026. At the average daily volume that is 3.13 days to cover. Short interest is reported twice a month; it is not today's figure.

Who owns 10x Genomics stock?

As reported by the data feed, institutions hold 114.2% of the shares (633 institutions) and insiders 1.4%. There are 121.46M shares outstanding, of which 119.47M are in the float.

How much does 10x Genomics stock move with the market?

Its beta, as reported by the data feed, is 2.03: a beta above 1 means the share has tended to move more than the market, below 1 less. Over the past 52 weeks it traded between $15.18 and $102.81.

Cite this page

Funkfolio, “10x Genomics (TXG) statistics: analyst targets and short interest”, data as of 17 November 2026. https://funkfolio.com/stock/TXG/statistics

Underlying data: Yahoo Finance.